RESUMEN
Three-dimensional (3D) printing has been gaining much attention in the medical field in recent years. At present, 3D printing most commonly contributes in pre-operative surgical planning of complicated surgery. It is also utilized for producing personalized prosthesis, well demonstrated by the customized rib cage, vertebral body models and customized airway splints. With on-going research and development, it will likely play an increasingly important role across the surgical fields. This article reviews current application of 3D printing in thoracic surgery and also provides a brief overview on the extended and updated use of 3D printing in bioprinting and 4D printing.
RESUMEN
Methods to improve accuracy of preclinical detection of bovine respiratory disease (BRD) are needed to reduce the economic impact of this disease, improve animal welfare, and promote more judicious use of antimicrobials in beef cattle. The objectives of this study were to retrospectively characterize time-series deviations in DMI and feeding behavior patterns preceding the display of observed clinical symptoms associated with BRD and to identify those feeding behavior traits that would be most predictive of BRD. The study was conducted with 231 seed stock bulls (391 ± 55 kg initial BW) representing 5 breeds that were housed in a facility equipped with GrowSafe feed bunks at a commercial bull-test facility. All bulls were vaccinated against standard viral and bacterial pathogens before and on arrival at the facility. Daily DMI and feeding behavior traits (frequency and duration of bunk visit events, head-down duration, variance of nonfeeding intervals, and time to approach feed bunk following feed-truck delivery) were measured for 70 d with a GrowSafe system. During a 10-d period from Day 28 to 37 of the trial, 30 bulls were administered antimicrobial therapy for clinical symptoms of BRD (rectal temperatures > 39.5°C). All remaining bulls ( = 201) were administered metaphylactic therapy on Day 38 of the trial in response to an acute decrease in feed intake. A retrospective analysis was conducted using a 2-slope broken-line regression model to identify inflection points in DMI and feeding behavior traits relative to onset of illness. The bulls were separated into 2 cohort groups based on observed clinical illness ( = 30) or those metaphylactically treated ( = 201), with the 2-slope broken-line regression model applied separately to each cohort. The model-detected inflection points for DMI were 6.8 and 3.8 d before observed clinical illness and metaphylactic treatment, respectively, and the reductions in DMI from detected inflection points to the day of observed clinical illness and day of metaphylactic treatment were 39.3 and 49.8%, respectively. Furthermore, the model-detected inflection points for individual feeding behavior traits ranged from 1.3 to 14.2 d before observed clinical illness and from 3.8 to 12.6 d before metaphylactic treatment. Results from this study demonstrate the potential value of electronic behavior-monitoring systems to improve the sensitivity and specificity of preclinical detection of BRD in feedlot cattle.
Asunto(s)
Complejo Respiratorio Bovino/diagnóstico , Conducta Alimentaria/fisiología , Animales , Antibacterianos/uso terapéutico , Complejo Respiratorio Bovino/tratamiento farmacológico , Complejo Respiratorio Bovino/patología , Bovinos , Masculino , Modelos Biológicos , Estudios RetrospectivosRESUMEN
Endometriosis-associated infertility has a multifactorial etiology. We tested the hypothesis that the endometrial response to the early embryonic signal, human chorionic gonadotropin (hCG), alters over time in a nonhuman primate model of endometriosis. Animals with experimental or spontaneous endometriosis were treated with hCG (30 IU/d), from d 6 after ovulation for 5 d, via an oviductal cannula. Microarray analysis of endometrial transcripts from baboons treated with hCG at 3 and 6 months of disease (n=6) identified 22 and 165 genes, respectively, whose levels differed more than 2-fold compared with disease-free (DF) animals treated with hCG (P<0.01). Quantitative RT-PCR confirmed abnormal responses of known hCG-regulated genes. APOA1, SFRP4, and PAPPA, which are normally down-regulated by hCG were up-regulated by hCG in animals with endometriosis. In contrast, the ability of hCG to induce SERPINA3 was lost. Immunohistochemistry demonstrated dysregulation of C3 and superoxide dismutase 2 proteins. We demonstrate that this abnormal response to hCG persists for up to 15 months after disease induction and that the nature of the abnormal response changes as the disease progresses. Immunohistochemistry showed that this aberrant gene expression was not a consequence of altered LH/choriogonadotropin receptor distribution in the endometrium of animals with endometriosis. We have shown that endometriosis induces complex changes in the response of eutopic endometrium to hCG, which may prevent the acquisition of the full endometrial molecular repertoire necessary for decidualization and tolerance of the fetal allograft. This may in part explain endometriosis-associated implantation failure.
Asunto(s)
Gonadotropina Coriónica/farmacología , Endometriosis/genética , Endometrio/efectos de los fármacos , Enfermedades Uterinas/genética , Animales , Biomarcadores Farmacológicos/metabolismo , Gonadotropina Coriónica/uso terapéutico , Análisis por Conglomerados , Modelos Animales de Enfermedad , Regulación hacia Abajo/efectos de los fármacos , Regulación hacia Abajo/genética , Endometriosis/tratamiento farmacológico , Endometriosis/metabolismo , Endometriosis/patología , Endometrio/metabolismo , Endometrio/patología , Femenino , Perfilación de la Expresión Génica , Genoma/efectos de los fármacos , Humanos , Masculino , Análisis de Secuencia por Matrices de Oligonucleótidos , Papio , Conejos , Enfermedades Uterinas/tratamiento farmacológico , Enfermedades Uterinas/metabolismo , Enfermedades Uterinas/patologíaRESUMEN
OBJECTIVE: To evaluate perioperative surgical outcomes and resection size for laparoscopically assisted radical vaginal hysterectomy (LARVH) compared with radical abdominal hysterectomy (RAH). DESIGN: A prospective randomised phase II trial. POPULATION: Early stage IB cervical cancer requiring radical surgical treatment. SETTING: Northern Gynaecological Oncology Centre, Gateshead, UK. METHODS: Fifteen women were randomised to LARVH and to RAH. MAIN OUTCOME MEASURES: Outcomes included requirement in days for bladder catheterisation after surgery, operating time, blood loss, hospital stay, opiate pain relief, complication rate, time to normal activities and resection size of major ligaments and vaginal cuff. Results Statistically significant differences were found between LARVH and RAH, respectively: median duration of bladder catheterisation, 4 days versus 21 days (P = 0.003); median operating time, 180 minutes versus 138 minutes (P = 0.05); median blood loss, 400 ml versus 1000 ml (P = 0.05), median hospital stay, 5 days versus 7 days (P = 0.04) and median opiate requirement in the first 36 hours postoperatively, 30 mg versus 53 mg (P = 0.004). The mean resected lengths for LARVH versus RAH, respectively, were: mean resected vaginal cuff, 1.26 cm versus 2.16 cm (P = 0.014); mean resected cardinal ligament length, 1.30 cm versus 2.79 cm (P = 0.013) and mean resected uterosacral ligament length, 1.47 cm versus 4.68 cm (P = 0.034). CONCLUSIONS: This study confirms the short-term surgical benefits of LARVH. In addition, LARVH has been shown to be a less radical procedure than RAH, supporting the need for strict patient selection and to restrict the procedure to small tumours.
Asunto(s)
Adenocarcinoma/cirugía , Carcinoma de Células Escamosas/cirugía , Histerectomía/métodos , Laparoscopía/métodos , Neoplasias del Cuello Uterino/cirugía , Adenocarcinoma/patología , Adulto , Carcinoma de Células Escamosas/patología , Femenino , Humanos , Complicaciones Intraoperatorias/etiología , Tiempo de Internación , Persona de Mediana Edad , Complicaciones Posoperatorias/etiología , Estudios Prospectivos , Resultado del Tratamiento , Neoplasias del Cuello Uterino/patologíaRESUMEN
Estrogen non-responsive estrogen receptor alpha (ERalpha) knock-in (ENERKI) mice have a mutation (glycine 525 to leucine, G525L) in the ligand-binding domain of ERalpha. The mutant ERalpha protein has a significantly lower affinity and response to endogenous estrogens, while not altering growth factor activated ligand-independent pathways. ENERKI females demonstrated signs of early follicle development as determined by a significant increase in antral follicle formation by 20 days of age. Adult ENERKI females were infertile, had hemorrhagic ovarian follicular cysts, and failed to develop corpora lutea in response to a superovulation regimen. These results illustrate the importance of ERalpha ligand-induced signaling for ovarian development and for estrogen feedback on the hypothalamus and pituitary. Although ERalpha ligand-induced signaling by endogenous estrogens is lost in ENERKI females, the ERalpha selective agonist propyl pyrazole triol (PPT), a synthetic nonsteroidal compound, is still able to activate G525L ERalphain vivo to increase uterine weight. To test whether PPT could restore ligand-dependent receptor activation, ENERKI females were treated with PPT and evaluated for spontaneous ovulation, ovarian hemorrhagic cysts, and LH serum levels. Daily PPT treatments beginning on day 4 of life prevented formation of ovarian hemorrhagic cysts in adult ENERKI animals. In accordance with this result, preputial gland weight and LH levels were also lowered in these animals, indicating PPT treatments most likely led to restoration of ERalpha negative feedback of the hypothalamic-pituitary axis.
Asunto(s)
Receptor alfa de Estrógeno/genética , Ovario/anomalías , Ovario/crecimiento & desarrollo , Animales , Esquema de Medicación , Receptor alfa de Estrógeno/metabolismo , Femenino , Técnicas de Sustitución del Gen , Hemorragia/prevención & control , Humanos , Infertilidad/genética , Ligandos , Masculino , Ratones , Folículo Ovárico/crecimiento & desarrollo , Ovario/fisiopatología , Fenoles , Fenotipo , Embarazo , Pirazoles/administración & dosificación , Pirazoles/farmacología , Conducta Sexual Animal , Transducción de Señal/genética , Superovulación/genéticaRESUMEN
Endometriosis is a poorly understood gynaecologic disorder that is associated with infertility. In this study, we examined the expression of HOXA10 in the eutopic endometrium of baboons with induced endometriosis. A decrease in HOXA10 mRNA was observed after 3, 6, 12 and 16 months of disease, which reached statistical significance at 12 and 16 months. HOXA10 protein levels were decreased in both the epithelial and stromal cells of the endometrium. Furthermore, expression of beta3 integrin (ITGB3), which is upregulated by HOXA10, was decreased, whereas EMX2, a gene that is inhibited by HOXA10, was increased. Next, methylation patterns of the HOXA10 gene were analysed in the diseased and control animals. The F1 region on the promoter was found to be the most significantly methylated in the endometriosis animals and this may account for the decrease in HOXA10 expression. Finally, we demonstrate that stromal cells from the eutopic endometrium of baboons with endometriosis expressed significantly higher levels of insulin-like growth factor binding protein-1 (IGFBP1) mRNA than disease-free animals in response to estradiol, medroxyprogesterone acetate and dibutyryl cAMP (H + dbcAMP). The functional role of HOXA10 in IGFBP1 expression was further explored using human endometrial stromal cells (HSC). Overexpression of HOXA10 in HSC resulted in a decrease of IGFBP1 mRNA, whereas silencing HOXA10 caused an increase of IGFBP1 mRNA, even in the presence of H + dbcAMP. These data demonstrate that HOXA10 negatively influences IGFBP1 expression in decidualizing cells. Thus, the decrease in HOXA10 levels may in part be involved with the altered uterine environment associated with endometriosis.
Asunto(s)
Decidua/metabolismo , Endometriosis/metabolismo , Endometrio/metabolismo , Proteínas de Homeodominio/metabolismo , Animales , Bucladesina/farmacología , Células Cultivadas , Metilación de ADN , Decidua/crecimiento & desarrollo , Decidua/patología , Endometriosis/patología , Endometrio/efectos de los fármacos , Endometrio/patología , Células Epiteliales/efectos de los fármacos , Células Epiteliales/metabolismo , Estradiol/farmacología , Femenino , Regulación de la Expresión Génica/efectos de los fármacos , Silenciador del Gen , Proteínas Homeobox A10 , Proteínas de Homeodominio/antagonistas & inhibidores , Proteínas de Homeodominio/genética , Proteínas de Homeodominio/fisiología , Humanos , Proteína 1 de Unión a Factor de Crecimiento Similar a la Insulina/metabolismo , Acetato de Medroxiprogesterona/farmacología , Papio , Regiones Promotoras Genéticas , ARN Mensajero/metabolismo , Células del Estroma/efectos de los fármacos , Células del Estroma/metabolismo , Factores de Transcripción/metabolismoAsunto(s)
Ingle/efectos de la radiación , Ganglios Linfáticos/diagnóstico por imagen , Radioterapia/métodos , Femenino , Humanos , Ganglios Linfáticos/efectos de la radiación , Metástasis Linfática/diagnóstico por imagen , Tomografía Computarizada por Rayos X , Neoplasias Uterinas/diagnóstico por imagen , Neoplasias Uterinas/patologíaRESUMEN
It is essential that any patient with resected vulval cancer and significant nodal disease receive optimal adjuvant treatment with radiation. Adequate radiotherapy for such patients with unilateral positive groin nodes has not been defined. Whether both groins and pelvic sidewalls should be irradiated or only the affected (node positive) side remains unclear. From our registry, we identified all patients with primary, previously untreated squamous cell carcinoma of the vulva undergoing bilateral inguinofemoral lymphadenectomy (superficial and deep nodes) and having unilaterally positive groin nodes treated with unilateral groin and pelvic radiotherapy (44 Gy in 22 fractions). Clinical and pathologic records were reviewed to identify the anatomical site and timing of recurrences in these patients and determine whether unilateral groin and pelvic irradiation was sufficient for disease control on the node-negative side. From 1983 to 2002, 20 patients with unilateral positive nodes treated with unilateral groin and pelvic irradiation were identified. Nineteen patients were classed as having FIGO stage III disease and one as FIGO stage IV due to involvement of the rectal mucosa. There were nine patients with disease recurrences in this group (45%). The disease-free interval ranged from 4 to 31 months (median time to recurrence, 9 months). All nine patients had local or regional failures, the most common site being the ipsilateral groin (six of nine patients). One patient was also found to have distant metastases. There were no recurrences noted in the contralateral (nonirradiated) groin or pelvic sidewall. Recurrence was generally fatal. Eight of the nine patients subsequently died of their disease. The ninth patient died of another cause. There was a high incidence of regional failure after unilateral groin and pelvic radiotherapy, but there were no recurrences on the nonirradiated, node-negative side. Although a small series, we speculate that there is no apparent disadvantage to administering unilateral adjuvant radiotherapy for unilaterally positive groin nodes and encourage further studies in order to more confidently determine whether the tendency observed in our center holds true.
Asunto(s)
Ganglios Linfáticos/patología , Recurrencia Local de Neoplasia/radioterapia , Neoplasias de la Vulva/patología , Neoplasias de la Vulva/radioterapia , Adulto , Factores de Edad , Anciano , Anciano de 80 o más Años , Biopsia con Aguja , Supervivencia sin Enfermedad , Femenino , Ingle/efectos de la radiación , Humanos , Inmunohistoquímica , Escisión del Ganglio Linfático , Ganglios Linfáticos/cirugía , Persona de Mediana Edad , Recurrencia Local de Neoplasia/mortalidad , Recurrencia Local de Neoplasia/patología , Estadificación de Neoplasias , Pelvis/efectos de la radiación , Pronóstico , Dosificación Radioterapéutica , Radioterapia Adyuvante , Sistema de Registros , Estudios Retrospectivos , Medición de Riesgo , Tasa de Supervivencia , Resultado del Tratamiento , Neoplasias de la Vulva/mortalidad , Neoplasias de la Vulva/cirugíaRESUMEN
Although the survival outcome for treated, early-stage, node-negative cervical cancer is excellent, the operation of radical hysterectomy conveys major morbidity, particularly with respect to bladder and bowel function. There may be some degree of spontaneous recovery, but a significant proportion of postoperative women will have to live with the disabling effects of surgery for decades, and few seek help for their distress. As such, quality of life issues have become highly relevant in the management of this disease, and attention has turned to reducing morbidity, especially to the pelvic viscera. This review presents an overview of the surgical mechanisms presumed to be responsible for pelvic floor denervation and describes subsequent bladder and bowel dysfunction, together with future possibilities for minimizing morbidity, including less radical, more individual surgery, and nerve-sparing techniques.
Asunto(s)
Histerectomía/efectos adversos , Complicaciones Posoperatorias/epidemiología , Calidad de Vida , Enfermedades del Recto/epidemiología , Enfermedades Urológicas/epidemiología , Neoplasias del Cuello Uterino/cirugía , Adulto , Anciano , Femenino , Humanos , Histerectomía/métodos , Incidencia , Persona de Mediana Edad , Morbilidad/tendencias , Diafragma Pélvico/fisiopatología , Pronóstico , Enfermedades del Recto/etiología , Medición de Riesgo , Enfermedades de la Vejiga Urinaria/epidemiología , Enfermedades de la Vejiga Urinaria/etiología , Enfermedades Urológicas/etiología , Neoplasias del Cuello Uterino/patologíaRESUMEN
OBJECTIVES: The technical feasibility of laparoscopically assisted radical vaginal hysterectomy has been well described, but its advantages over the open technique remain largely unproven. We reviewed and compared our experiences with both approaches. METHODS: All patients undergoing laparoscopically assisted radical vaginal hysterectomy (LARVH) between 1996 and 2003 were identified and matched for age, FIGO stage, histological subtype and nodal metastases using a control group of women who underwent radical abdominal hysterectomy (RAH) during the same time period. RESULTS: Fifty-seven women were listed for LARVH, resulting in five conversions. Fifty cases were matched successfully using the criteria above. The majority of cases were FIGO stage 1B1. Statistically significant differences (P < 0.05) were present when the following were compared for LARVH vs. RAH: duration of surgery (median 180 vs. 120 min), blood loss (median 350 vs. 875 ml), hospital stay (median 5 days vs. 8 days) and duration of continuous bladder catheterisation (median 3 days vs. 7 days). There were no statistically significant differences with regard to nodal yield, completeness of surgical margins or perioperative complication rate. Four major complications (8%, three cystotomies and one enterotomy) occurred in the LARVH group and three in the RAH group (6%, one pulmonary embolism, one ureteric injury and one major haemorrhage). Three women in LARVH group had seen a specialist regarding postoperative bladder dysfunction, versus 12 in the RAH group (P = 0.04). No patients in the LARVH group reported constipation requiring regular laxatives, versus six in the RAH group (P = 0.03). Median follow-up was 52 months for LARVH and 49 months for RAH. There was no significant difference between recurrence rates or overall survival (94% for LARVH vs. 96% for RAH). CONCLUSIONS: Despite the inherent limitations of LARVH and its associated learning curve, the procedure conveys many advantages over the open technique in terms of blood loss, transfusion requirement and hospital stay. In addition, the incidence of postoperative bladder and bowel dysfunction appears low-suggesting improved quality of life-without compromising survival.
Asunto(s)
Histerectomía/métodos , Neoplasias del Cuello Uterino/cirugía , Adulto , Anciano , Anciano de 80 o más Años , Enfermedades Funcionales del Colon/etiología , Femenino , Humanos , Histerectomía/efectos adversos , Histerectomía Vaginal/efectos adversos , Histerectomía Vaginal/métodos , Laparoscopía/efectos adversos , Laparoscopía/métodos , Persona de Mediana Edad , Morbilidad , Recurrencia Local de Neoplasia , Enfermedades de la Vejiga Urinaria/etiologíaRESUMEN
BACKGROUND: The majority of vulval cancers are of the squamous cell type. Current operative management strategies are based on modifications of radical vulvectomy and groin node dissection, enabling a more individualised and conservative approach to surgery. This has led to interesting dilemmas regarding the most appropriate management in certain individuals. CASE: We describe a case of a contralateral recurrence following unilateral groin node dissection for vulval cancer, with an initial single microscopically positive node. The patient did not receive adjuvant treatment. Evidence regarding the safety of this approach is discussed. CONCLUSION: The subject remains controversial, and further such cases should be recorded in the literature in order to gather more information on this difficult problem.
Asunto(s)
Procedimientos Quirúrgicos Ginecológicos/métodos , Escisión del Ganglio Linfático/métodos , Recurrencia Local de Neoplasia/etiología , Neoplasias de la Vulva/cirugía , Anciano , Femenino , Humanos , Conducto Inguinal/cirugía , Metástasis Linfática , Neoplasias de la Vulva/patologíaRESUMEN
During the past decade, botulinum toxin (Botox) has emerged as the accepted treatment for adductor spasmodic dysphonia (ASD). This therapy, which produces bilateral weakness of the thyroarytenoid muscle, undoubtedly produces physiologic effects that are beneficial to patients with ASD. However, it also has important limitations, including the need for repeated injections, the unpredictable relationship between dosage and response, and the possibility of short-term swallowing and voice problems. In this study, we will report our preliminary experience with a new surgical treatment for ASD. In this new procedure, the adductor branch of the recurrent laryngeal nerve is selectively denervated bilaterally, and its distal nerve stumps are reinnervated with branches of the ansa cervicalis nerve. Each of the patients was followed for at least 12 months; the median follow-up is 36 months. The outcome of the operation in 21 consecutive patients is reported. Nineteen of the 21 patients were judged to have an overall severity of dysphonia that was "absent to mild" following the procedure. Only 1 patient underwent further treatment with Botox postoperatively. The implications of this new procedure for ASD are discussed.
Asunto(s)
Músculos Laríngeos/inervación , Desnervación Muscular , Nervio Laríngeo Recurrente/cirugía , Trastornos de la Voz/cirugía , Femenino , Estudios de Seguimiento , Humanos , Masculino , Transferencia de Nervios , Procedimientos Quirúrgicos Otorrinolaringológicos/métodos , Satisfacción del Paciente , Complicaciones Posoperatorias , Calidad de la VozRESUMEN
Every nurse executive is responsible for maintaining compliance to current externally established standards. As standards change, the nurse executive must evaluate the organization, making sure it continues to demonstrate compliance. This article describes how one organization used the Joint Commission on Accreditation of Healthcare Organizations' Agenda for Change as an opportunity to examine its nursing practice. The process included: 1) analyzing compliance to the 1991 standards; 2) developing an action plan to address deficiencies; and 3) developing and conducting a mock survey to monitor and evaluate effectiveness of the action plan. Increased staff comfort with the survey process, monitoring tools, and data regarding compliance to standards were the primary outcomes of this process. Leadership development, team building, and networking were also outcomes.